SLC13A5 and Onset: Loss-of-function mutations in SLC13A5 have been associated with early-onset epilepsy, but the role of citrate metabolism in the pathophysiology of these patients is not well understood (Hardies et al., 2015; Klotz et al., 2016; Thevenon et al., 2014).